Furiex Pharmaceuticals, Inc. 4
4 · Furiex Pharmaceuticals, Inc. · Filed Aug 13, 2013
Insider Transaction Report
Form 4
CORR PETER B
Director
Transactions
- Exercise/Conversion
Common Stock
2013-08-09$9.11/sh+7,500$68,325→ 11,080 total - Sale
Common Stock
2013-08-09$39.74/sh−7,500$298,050→ 3,580 total - Exercise/Conversion
Stock Options (to buy)
2013-08-09−7,500→ 5,470 totalExercise: $9.11Exp: 2020-06-17→ Common Stock (7,500 underlying)
Holdings
- 8,825
Stock Options (to buy)
Exercise: $13.45Exp: 2021-10-12→ Common Stock (8,825 underlying) - 8,675
Stock Options (to buy)
Exercise: $13.94Exp: 2021-05-19→ Common Stock (8,675 underlying) - 17,500
Stock Options (to buy)
Exercise: $18.22Exp: 2022-05-24→ Common Stock (17,500 underlying)
Footnotes (4)
- [F1]The options were awarded on 6/17/2010 and vest and become exercisable in full on the earlier of the first anniversary of the date of grant or immediately prior to the next election of directors of the Company, provided that the Optionee is still at that time serving on the Company's Board of Directors.
- [F2]The options were awarded on 5/19/2011 and vest and become exercisable in full on the earlier of the first anniversary of the date of grant or immediately prior to the next election of directors of the Company, provided that the Optionee is still at that time serving on the Company's Board of Directors.
- [F3]The options were awarded on 10/12/2011 and vest and become exercisable in full on the earlier of 5/19/2012 or immediately prior to the next election of directors of the Company, provided that the Optionee is still at that time serving on the Company's Board of Directors.
- [F4]The options were awarded on 5/24/2012 and vest and become exercisable in full on the earlier of 5/24/2013 or immediately prior to the next election of directors of the Company, provided that the Optionee is still at that time serving on the Company's Board of Directors.